Delaware Bio accelerates mutually beneficial relationships with the federal delegation in Washington, D.C.
DELAWARE BIO REGULARLY COMMUNICATES WITH DELAWARE'S SENATORS AND CONGRESSWOMAN ON THE FEDERAL POLICY ISSUES THAT RELATE TO OUR INDUSTRY.
EDUCATING ON THE VALUE OF BIOMEDICAL INNOVATION
Which improves quality of life, limits costs to the healthcare system, and gives patients time to live fuller lives
THE PRESERVATION OF THE CURRENT VERSION OF MEDICARE PARTS B & D
Which allow for lower costs for the Medicare program as well as better outcomes for the beneficiaries
THE CONTINUED FUNDING OF THE NATIONAL INSTITUTES OF HEALTH (NIH)
Which is important for groundbreaking medical research
THE CONTINUED FUNDING OF THE FOOD AND DRUG ADMINISTRATION (FDA)
To quicken the approval process so life-saving treatments reach patients. The FDA also contributes to food safety
PROGRESS IN THE RENEWABLE FUEL STANDARD
To ensure America’s path towards energy independence, is important to many companies in our state, as well as institutions conducting research like the University of Delaware and Delaware State University
ENCOURAGING A NATIONWIDE STANDARD FOR LABELING OF FOODS
With genetically modified ingredients (GMOs), as an alternative to expensive and complex state-by-state laws
STRENGTHENING PROTECTION OF CORPORATE TRADE SECRETS AND REFORMING THE INTELLECTUAL PROPERTY (PATENT LAW) SYSTEM
Both of which are crucial to innovative discoveries – the lifeblood of our industry – reaching the marketplace